| __timestamp | MannKind Corporation | Viatris Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 79383000 | 1499100000 |
| Thursday, January 1, 2015 | 108402000 | 1923500000 |
| Friday, January 1, 2016 | 46928000 | 2351400000 |
| Sunday, January 1, 2017 | 74959000 | 2564000000 |
| Monday, January 1, 2018 | 79716000 | 2397300000 |
| Tuesday, January 1, 2019 | 74669000 | 2503400000 |
| Wednesday, January 1, 2020 | 59040000 | 3344600000 |
| Friday, January 1, 2021 | 77417000 | 4529200000 |
| Saturday, January 1, 2022 | 91473000 | 4179100000 |
| Sunday, January 1, 2023 | 94314000 | 4650100000 |
Unlocking the unknown
In the ever-evolving pharmaceutical landscape, understanding operational efficiency is crucial. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of Viatris Inc. and MannKind Corporation from 2014 to 2023. Viatris, a global healthcare giant, consistently reported higher SG&A expenses, peaking at approximately $4.65 billion in 2023. This represents a staggering 210% increase from 2014. In contrast, MannKind, a smaller player, saw its SG&A expenses rise by about 19% over the same period, reaching nearly $94 million in 2023.
While Viatris's expenses reflect its expansive operations, MannKind's leaner approach highlights its focus on niche markets. The data underscores the diverse strategies within the industry, offering a window into how companies allocate resources to drive growth and innovation.
Who Optimizes SG&A Costs Better? Novo Nordisk A/S or MannKind Corporation
Pfizer Inc. and Viatris Inc.: SG&A Spending Patterns Compared
Breaking Down SG&A Expenses: GSK plc vs Viatris Inc.
Breaking Down SG&A Expenses: Takeda Pharmaceutical Company Limited vs Viatris Inc.
Teva Pharmaceutical Industries Limited and Viatris Inc.: SG&A Spending Patterns Compared
Breaking Down SG&A Expenses: Viatris Inc. vs Cytokinetics, Incorporated
Comparing SG&A Expenses: Viatris Inc. vs Pharming Group N.V. Trends and Insights
Breaking Down SG&A Expenses: Viatris Inc. vs PTC Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Viatris Inc. and Bausch Health Companies Inc.
Cost Management Insights: SG&A Expenses for Viatris Inc. and ImmunityBio, Inc.
Dr. Reddy's Laboratories Limited and MannKind Corporation: SG&A Spending Patterns Compared
MannKind Corporation and Novavax, Inc.: SG&A Spending Patterns Compared